Two Sigma Investments’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,268
Closed -$23.7K 3780
2025
Q2
$23.7K Buy
+2,268
New +$31K ﹤0.01% 3110
2022
Q3
Sell
-1,524
Closed -$37K 2624
2022
Q2
$37K Sell
1,524
-1,199
-44% -$43.9K ﹤0.01% 2363
2022
Q1
$180K Buy
2,723
+1,157
+74% +$90.8K ﹤0.01% 2353
2021
Q4
$165K Buy
1,566
+1,307
+505% +$204K ﹤0.01% 3973
2021
Q3
$47K Sell
259
-306
-54% -$63.5K ﹤0.01% 4149
2021
Q2
$140K Buy
+565
New +$134K ﹤0.01% 3859
2020
Q4
Sell
-1,186
Closed -$170K 3524
2020
Q3
$170K Sell
1,186
-413
-26% -$104K ﹤0.01% 2855
2020
Q2
$1.16M Buy
+1,599
New +$693K 0.01% 1443
2013
Q4
Sell
-1
Closed -$12K 2265
2013
Q3
$12K Buy
+1
New +$14.8K ﹤0.01% 1800

Other funds holding IMNN

Two Sigma Investments's IMNN Position: Q3 2025 in Review

Two Sigma Investments sold out of Imunon (IMNN) in Q3 2025, closing a stake of 2,268 shares — an estimated $23.7K sold.

Two Sigma Investments first reported a position in IMNN in Q3 2013 and held it in 9 quarters. The position peaked at $1.16M in Q2 2020. 17 funds tracked by Wall St. Rank hold IMNN as of Q3 2025.

  • Two Sigma Investments reported no remaining Imunon position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 2,268 Imunon shares in Q3 2025, an estimated $23.7K.
  • Two Sigma Investments first reported a position in Imunon in Q3 2013 and held it in 9 quarters.
  • Two Sigma Investments's Imunon position peaked at $1.16M in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Imunon as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.